Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)
- PMID: 30442772
- DOI: 10.1136/bmj.k4691
Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)
Erratum for
-
Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).BMJ. 2018 Oct 31;363:k4218. doi: 10.1136/bmj.k4218. BMJ. 2018. PMID: 30381374 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources